← Evidence map

ArticleOphthalmology and therapy2026

Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized).

Dorota Raczynska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized). | OpenQuestion